Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
62 participants
INTERVENTIONAL
2004-06-30
2012-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Also, the investigators are interested in investigating this group of patients on psychiatric and somatic comorbidity, personality traits, and startle response to sounds.
The investigators will also study the audiological measures commonly used in Sweden to measure hyperacusis, and investigate their validity.
The investigators hypothesize that CBT might be helpful for patients suffering from Hyperacusis.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Role of Exposure in Hyperacusis
NCT04705246
Efficacy of Treatment for Tinnitus
NCT02632058
Using Neurostimulation to Accelerate Change in Misophonia: a Pilot Study
NCT06333925
Hearing Impairment, Cognitive Therapy and Coping
NCT01206829
Identifying the Optimal Neural Target for Misophonia Interventions
NCT04348591
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Cognitive behavioural therapy (CBT)
Patients receiving 6 sessions of CBT conducted by a licensed psychologist. Sessions include psychoeducation, exposure treatment, behavioral activation and applied relaxation.
Cognitive behavioural therapy
6 sessions by licensed psychologist, including psychoeducation, exposure therapy, applied relaxation and behavioral activation.
Waiting list
Patient waits for CBT treatment for 6 months.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Cognitive behavioural therapy
6 sessions by licensed psychologist, including psychoeducation, exposure therapy, applied relaxation and behavioral activation.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Hyperacusis is the primary audiological problem
* Loudness discomfort thresholds below 90 dB
* Hearing levels better than 40dB on the best ear
* Resident of Uppsala, Stockholm or Vastmanland
* Possibility to travel to Uppsala or Vasteras for examination and treatment
Exclusion Criteria
* Moderate to severe depression
* Psychotic disorders
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Uppsala University
OTHER
Uppsala University Hospital
OTHER
Linkoeping University
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Gerhard Andersson
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Lisa Ekselius, Professor
Role: STUDY_DIRECTOR
Uppsala University
Gerhard Andersson, Professor
Role: STUDY_CHAIR
Linkoeping University
Hans C Larsen, Reader
Role: STUDY_CHAIR
Uppsala University Hospital
Linda Jüris, PhD Student
Role: PRINCIPAL_INVESTIGATOR
Uppsala University/ Uppsala University Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Uppsala, , Sweden
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
GA-LJ-HYP1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.